Overview

A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

Status:
Withdrawn

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

This is a single arm, open label study of up to 20 patients with prostate cancer scheduled for prostatectomy at the NIH Clinical Center. 123I-MIP-1072 image data will be evaluated for visible uptake and compared with histopathology.

Details

Lead Sponsor:

Molecular Insight Pharmaceuticals, Inc.

Collaborator:

National Cancer Institute (NCI)